Medical News

RSS

Critical care Breathe Technologies Life2000 Ventilation System receives FDA clearance

Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.

15 Jun 2015

BioLight expands relationship with Ora to develop TeaRx multi-parameter diagnostic test for DES

BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a Collaboration Agreement (the "Agreement") pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight's TeaRx multi-parameter diagnostic test for dry eye syndrome ("DES").

15 Jun 2015

OmniVision introduces CameraChip sensor for medical and industrial applications

OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced a new ultra-compact CameraChip sensor for medical and industrial applications.

15 Jun 2015

Laurent reports positive topline results from LAU-7b Phase 1b trial in adult CF patients

Laurent Pharmaceuticals Inc. announced today positive topline results from a Phase 1b clinical trial with LAU-7b in adult CF patients. LAU-7b is a novel oral formulation of fenretinide, a synthetic retinoid investigated for its lipid modulating properties and potential to address the aberrant inflammatory response in CF.

15 Jun 2015

Scientists find way to accelerate wound healing in diabetic mice

One of the body's own tools for preventing wound infections may actually interfere with wound healing, according to new research from Boston Children's Hospital. In a study published online in Nature Medicine, scientists from the hospital's Program in Cellular and Molecular Medicine found they could speed up wound healing in diabetic mice by keeping immune cells called neutrophils from producing bacteria-trapping neutrophil extracellular traps (NETs).

15 Jun 2015

Nutrinia's NTRA-9620 granted FDA orphan drug designation for treatment of short bowel syndrome

Nutrinia, developing therapies to treat rare gastrointestinal disorders, announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for the company's orally-administered drug for treating short bowel syndrome (SBS) in patients of all ages. Nutrinia plans to begin a pivotal clinical trial in this indication.

15 Jun 2015

Men's poor health costs $36.9 billion a year for Canada

Canadian Men's Health Week is kicking off with an urgent message: Unhealthy lifestyle choices are running rampant, and they are costing this country an arm and a leg.

15 Jun 2015

Actavis adopts Allergan as its new global name

Actavis plc announced that the company has adopted Allergan plc as its new global name and will begin trading today under a new symbol — AGN — after ringing The Opening Bell at the New York Stock Exchange.

15 Jun 2015

CVS Health signs definitive agreement to acquire Target's pharmacy and clinic businesses for $1.9 billion

CVS Health Corporation and Target Corporation announced today that they have entered into a definitive agreement for CVS Health to acquire Target's pharmacy and clinic businesses for approximately $1.9 billion. Through this agreement, CVS Health will acquire Target's more than 1,660 pharmacies across 47 states and operate them through a store-within-a-store format, branded as CVS/pharmacy.

15 Jun 2015

DATATRAK International introduces next generation clinical trial management system

DATATRAK International, Inc., the leader in developing cloud-based, unified dClinical® technologies and delivering related services for the clinical trials industry, today introduced the next generation clinical trial management system, UX CTMS 360.

15 Jun 2015

Genesis inks asset purchase agreement with Revera

Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced that it has signed an asset purchase agreement with Revera Inc., a leading owner, operator and investor in the senior living sector, to acquire 24 of its skilled nursing facilities along with its contract rehabilitation business for $240 million.

15 Jun 2015

PTI to develop unique 3D game-based learning platform for pharma, biotech and medical device sectors

Pharmaceutical Training International, the leading supplier of online and public event-based training courses for the pharma, biotech and medical device sectors, has expanded its game-based learning platform into a fully customisable virtual learning environment.

From Pharmaceutical Training International 15 Jun 2015

Juniper announces enrollment of first patient in COL-1077 Phase II trial to reduce pain during endometrial biopsy

Juniper Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of therapeutics for women's health, announced today the first patient has been enrolled in a Phase II clinical trial of COL-1077, a 10% lidocaine bioadhesive gel that is intended as an acute-use anesthetic during minimally invasive gynecologic procedures.

15 Jun 2015

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

BIAL is presenting 11 research posters at the 19th International Congress of Parkinson's Disease and Movement Disorders (June 14–15, San Diego, CA). These evaluate the safety and efficacy of opicapone (BIA 9-1067), a novel once-daily catechol-O-methyltransferase (COMT) inhibitor for use as adjunctive therapy in levodopa-treated Parkinson’s disease patients with end of dose motor fluctuations.

15 Jun 2015

Novartis announces FDA approval of Promacta for treatment of children with chronic ITP

Novartis announced today that the US Food and Drug Administration has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.

15 Jun 2015

Novasep announces launch of BioSC Lab for protein purification

Novasep, a leading supplier of manufacturing solutions to the life science industries, today announces the launch of BioSC Lab, the next-generation low pressure chromatography equipment for the biopharmaceutical industry.

15 Jun 2015

New study explores positive, negative aspects of parenting in mothers and fathers

Mothers’ and fathers’ parenting behaviour is more likely to resemble their own mothers’ than their fathers’, according to a new study.

15 Jun 2015

Vitamin D supplementation may treat Crohn’s disease

New research published in this month’s edition of United European Gastroenterology Journal suggests that supplementation with vitamin D may impact on the intestinal barrier dysfunction associated with Crohn’s disease, and could have a role in the treatment of the condition.

15 Jun 2015

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Ventana Medical Systems, Inc., a member of the Roche Group, today announced approval of the VENTANA ALK (D5F3) CDx Assay by the US Food and Drug Administration as a companion diagnostic to aid in the identification of patients for Pfizer's FDA approved targeted therapy, XALKORI (crizotinib).

15 Jun 2015

Poll: 60% of U.S. adults favor complete ban on powdered alcohol

After this year's legalization of powdered alcohol, some states have already banned it -- a move that the majority of the public supports, according to a new University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health.

15 Jun 2015

Medical News

Critical care Breathe Technologies Life2000 Ventilation System receives FDA clearance

BioLight expands relationship with Ora to develop TeaRx multi-parameter diagnostic test for DES

OmniVision introduces CameraChip sensor for medical and industrial applications

Laurent reports positive topline results from LAU-7b Phase 1b trial in adult CF patients

Scientists find way to accelerate wound healing in diabetic mice

Nutrinia's NTRA-9620 granted FDA orphan drug designation for treatment of short bowel syndrome

Men's poor health costs $36.9 billion a year for Canada

Actavis adopts Allergan as its new global name

CVS Health signs definitive agreement to acquire Target's pharmacy and clinic businesses for $1.9 billion

DATATRAK International introduces next generation clinical trial management system

Genesis inks asset purchase agreement with Revera

PTI to develop unique 3D game-based learning platform for pharma, biotech and medical device sectors

Juniper announces enrollment of first patient in COL-1077 Phase II trial to reduce pain during endometrial biopsy

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

Novartis announces FDA approval of Promacta for treatment of children with chronic ITP

Novasep announces launch of BioSC Lab for protein purification

New study explores positive, negative aspects of parenting in mothers and fathers

Vitamin D supplementation may treat Crohn’s disease

VENTANA ALK (D5F3) CDx Assay receives FDA approval

Poll: 60% of U.S. adults favor complete ban on powdered alcohol

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News